Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,714 | 128,058 | 191,442 | 113,556 | 144,895 |
| Marketable Securities | 200,450 | 88,916 | 9,952 | 116,039 | 74,915 |
| Receivables | 7,905 | 2,368 | 64 | 588 | 132 |
| Other current assets | 3,895 | 2,297 | 2,561 | 2,955 | 2,333 |
| TOTAL | $305,700 | $232,756 | $215,339 | $244,070 | $229,218 |
| Non-Current Assets | |||||
| PPE Net | 3,146 | 3,909 | 5,823 | 6,675 | 4,139 |
| Investments And Advances | 106,260 | 29,824 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,328 | 5,066 | 7,180 | 5,322 | 5,508 |
| TOTAL | $112,734 | $38,799 | $13,003 | $11,997 | $9,647 |
| Total Assets | $418,434 | $271,555 | $228,342 | $256,067 | $238,865 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,939 | 2,498 | 1,695 | 766 | 2,385 |
| Accrued Expenses | 41,035 | 18,567 | 13,815 | 15,748 | 14,754 |
| TOTAL | $57,875 | $40,056 | $30,819 | $31,394 | $17,139 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,901 | 18,991 | 15,309 | 14,880 | N/A |
| Other Non-Current Liabilities | 1,141 | 2,478 | 4,884 | 2,968 | 3,949 |
| TOTAL | $8,102 | $2,478 | $37,958 | $39,824 | $3,949 |
| Total Liabilities | $65,977 | $42,534 | $68,777 | $71,218 | $21,088 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,151 | 54,078 | 46,304 | 44,148 | 37,359 |
| Common Shares | 5 | 5 | 5 | 4 | 4 |
| Retained earnings | -497,715 | -490,830 | -401,849 | -297,150 | -196,083 |
| Other shareholders' equity | 543 | -151 | -24 | -1,175 | -168 |
| TOTAL | $352,457 | $229,021 | $159,565 | $184,849 | $217,777 |
| Total Liabilities And Equity | $418,434 | $271,555 | $228,342 | $256,067 | $238,865 |